Prosecution Insights
Last updated: October 02, 2026
Application No. 18/938,595

DRESSINGS AND MEDICATED PADS FOR REMOVING SKIN DISORDERS

Non-Final OA §102
Filed
Nov 06, 2024
Priority
Nov 13, 2023 — provisional 63/598,177
Examiner
PACKARD, BENJAMIN J
Art Unit
Tech Center
Assignee
Delstar Technologies Inc.
OA Round
1 (Non-Final)
67%
Grant Probability
Favorable
1-2
OA Rounds
1y 0m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
894 granted / 1341 resolved
+6.7% vs TC avg
Strong +16% interview lift
Without
With
+15.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
45 currently pending
Career history
1389
Total Applications
across all art units

Statute-Specific Performance

§101
2.2%
-37.8% vs TC avg
§103
47.9%
+7.9% vs TC avg
§102
16.1%
-23.9% vs TC avg
§112
15.6%
-24.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1341 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-21 are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by Cline et al (US 6,656,495). Cline et al discloses an oval wart or callus removal pad comprising a first layer with adhesive (item 14 in figs), a circular second layer with the actives which is on the first layer (item 18 in fig), and a third layer comprising a hydrogel surrounding the second layer (hydrocolloid adhesive layer item 12 in figures) (col 4 to col 6 and claims). The pads are disclosed to contain 42% salicylic acid by weight or 36% by weight (col 6 lines 6-23). The third and outer layers may include a polyester, polypropylene, or polyolefin film (col 3 lines 8-10). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BENJAMIN J PACKARD whose telephone number is (571)270-3440. The examiner can normally be reached Mon 2-6pm and Tues-Fri 9:30am-6:30pm + mid-day flex. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana S. Kaup can be reached at (571) 272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BENJAMIN J PACKARD/ Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Nov 06, 2024
Application Filed
Jun 29, 2026
Non-Final Rejection mailed — §102
Sep 28, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746227
BENZIMIDAZOLE COMPOUND FOR THE TREATMENT OF METABOLIC DISORDERS
4y 0m to grant Granted Sep 29, 2026
Patent 12746296
IODINE LABELED HYDROGELS AND PRECURSORS THEREOF WITH IMPROVED RADIOPACITY
3y 11m to grant Granted Sep 29, 2026
Patent 12740933
WATER-IN-OIL EMULSION COSMETIC
2y 5m to grant Granted Sep 22, 2026
Patent 12740923
PHARMACEUTICAL FORMULATION
1y 8m to grant Granted Sep 22, 2026
Patent 12735581
ANTIFOULING COMPOUNDS
3y 5m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
67%
Grant Probability
82%
With Interview (+15.6%)
2y 11m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1341 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month